Outcomes of Cardiac Transplantation in Single-Ventricle Patients With Plastic Bronchitis: A Multicenter Study  by Gossett, Jeffrey G. et al.
t
a
P
u
w
H
l
h
p
l
e
p
a
O
n
(
9
c
2
f
d
H
g
g
s
d
l
o
3
Journal of the American College of Cardiology Vol. 61, No. 9, 2013
© 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc.CORRESPONDENCE
Research
Correspondence Outcomes of Cardiac Transplantation
in Single-Ventricle Patients With
Plastic Bronchitis: A Multicenter Study
c
O
g
m
p
c
a
N
r
a
S
w
s
p
p
c
c
2
P
(
s
t
c
o
p
g
t
a
r
d
fi
p
t
o
r
n
o
i
u
o
s
eTo the Editor: Plastic bronchitis (PB) is a rare condition charac-
erized by formation of airway casts that obstruct the bronchial tree
nd cause respiratory failure. In the congenital cardiac population,
B occurs mostly in patients with single ventricle (SV) defects
ndergoing Fontan palliation. Mortality for PB is as high as 29%,
ith life-threatening events occurring in 41% (1). Reports on PB
are limited, and it is unclear which, if any, therapy is effective; the
effect of heart transplantation (HTx) on PB remains unclear (2).
Using a multicenter pediatric HTx database, we investigated the
outcome of SV patients listed for HTx with a diagnosis of PB and
whether HTx led to resolution of PB.
The Pediatric Heart Transplant Study is an international
registry acquiring data from 35 centers. A supplemental form was
generated for patients listed for HTx between January 1993 and
December 2009 and censored on December 31, 2010, ensuring 12
months of follow-up. Centers were provided with a list of their SV
patients, regardless of surgical stage, and completed the form for
any patient with PB. The diagnosis of PB was made clinically (i.e.,
presence of airway casts) and was not adjudicated.
There were 937 SV patients among 4,319 transplant patients.
Ten of 35 centers contributed a total of 14 patients with PB who
constitute our study group. PB patients were compared with 2
groups: all other SV patients (n  923) and all other Pediatric
eart Transplant Study patients (n  4,305). Median age at
isting for study group was 6.3 years (range 3.2 to 13.6 years). All
ad completed Fontan procedures, and the median time from the
rocedure to listing was 1.9 years (range 0.1 to 10 years). Patients
isted with PB were older and had a higher body surface area than
ither comparison group (p  0.05). Compared with the overall
opulation, patients with PB were less likely to be listed status 1
nd more likely to have had a previous sternotomy (p  0.05).
nly 1 patient with PB had protein-losing enteropathy; there was
o difference between the groups in serum albumin levels at listing
available starting 1999; n  13). Cast pathology was available for
patients: 3 mucinous (acellular), 4 mucinous with inflammatory
ells, and 2 chylous (fibrinous).
Ten (71%) of 14 patients with PB underwent HTx. There were
wait-list deaths (1 intracranial hemorrhage, 1 multiorgan system
ailure); 1 remained listed at study termination; and 1 patient was
elisted (deemed “too well”). There was no difference in survival to
Tx between patients with PB and patients from either control
roup (Fig. 1A). Peritransplantation survival was worse in the PB
roup than in controls, with 7 (70%) of 10 patients with PB
urviving to 30 days post-HTx (Fig. 1B). There were 3 early
eaths: postoperative days 6 (graft failure), 14 (graft dysfunction,
ung disease, and renal failure), and 26 (anoxia, pulmonary hem-
rrhage, and renal failure). All 7 patients with PB who survived to
0 days were still alive at 1 and 5 years, with no difference in ponditional survival compared with the control groups (Fig. 1C).
verall 5-year outcomes for PB patients were equivalent to control
roups (Fig. 1D).
In the 10 transplanted patients, casts were documented a
edian of 10.5 days (range 1 to 1.1 years) before HTx. Two
atients had early evidence of PB after HTx with production of
asts. One died on postoperative day 6 of primary graft failure,
nd the other had resolution of casts after postoperative day 20.
one of the 7 patients surviving more than 30 days had any
ecurrence of casts at a mean of 5.7 years (range 0.8 to 7.7 years)
fter HTx, with a cumulative follow-up of 30.8 patient-years.
In this multicenter report, we show that long-term survival of
V patients undergoing HTx in the setting of PB compares well
ith the general pediatric HTx population. In addition, we have
pecifically addressed the question of whether HTx for SV
atients with PB leads to a durable resolution of the PB. In all
atients surviving to 30 days after HTx, there was complete
essation of cast formation. Furthermore, we have personal
ommunication (J Gossett [October 2012], B Kaufman [March
011], J Scheel [March 2011]) regarding 3 other patients with
B who have had complete resolution of their PB after HTx
transplanted since termination of enrollment in the current
tudy).
Multiple therapies for PB in SV patients have been at-
empted and reported in the literature, primarily directed at
learing severe airway obstruction but some aimed at resolution
f cast formation. Almost all reports are isolated to single
atients and centers (1,2). We separated these reports into two
roups based on whether the therapy was proposed to have led
o a complete resolution of cast formation. We found that in
lmost all cases the same therapy reported to have led to
esolution of PB had also been reported to not result in a
urable cessation of cast production in other accounts. This
nding raises questions about the effectiveness of any other
roposed therapies.
Although we believe that we have captured the majority of
he field’s experience with transplantation in the setting of PB,
ur population is small and may not be representative. Our
eport identified SV patients listed in the setting of PB and may
ot represent the overall population with PB. Extrapolation of
ur data to all PB patients may not be appropriate. We did not
nvestigate patients for whom alternative therapies for PB were
sed and are therefore unable to compare these against the
utcomes for HTx. Thus, we do not suggest that HTx is
uperior to alternative treatments but rather that it is an
ffective option in this setting and that it seems superior to
ublished outcomes.
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March 5, 2013:985–91In summary, transplantation is a viable solution for SV
patients with a diagnosis of PB. Transplantation leads to
resolution of cast formation early postoperatively and to a
durable resolution of PB. Although early mortality is high,
conditional and long-term survival compares well with results in
other pediatric HTx recipients.
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